1. Glucocorticoid-related genetic susceptibility for Alzheimer's disease.
- Author
-
de Quervain DJ, Poirier R, Wollmer MA, Grimaldi LM, Tsolaki M, Streffer JR, Hock C, Nitsch RM, Mohajeri MH, and Papassotiropoulos A
- Subjects
- 11-beta-Hydroxysteroid Dehydrogenase Type 1 analogs & derivatives, 11-beta-Hydroxysteroid Dehydrogenase Type 1 metabolism, Aged, Cells, Cultured, Europe, Gene Components, Genetic Vectors, Genotype, Haplotypes genetics, Humans, Luciferases, Polymorphism, Single Nucleotide genetics, Risk Factors, Transfection, 11-beta-Hydroxysteroid Dehydrogenase Type 1 genetics, Alzheimer Disease genetics, Gene Expression Regulation, Genetic Predisposition to Disease genetics, Glucocorticoids metabolism
- Abstract
Because glucocorticoid excess increases neuronal vulnerability, genetic variations in the glucocorticoid system may be related to the risk for Alzheimer's disease (AD). We analyzed single-nucleotide polymorphisms in 10 glucocorticoid-related genes in a population of 814 AD patients and unrelated control subjects. Set-association analysis revealed that a rare haplotype in the 5' regulatory region of the gene encoding 11beta-hydroxysteroid dehydrogenase type 1 (HSD11B1) was associated with a 6-fold increased risk for sporadic AD. Results of a reporter-gene assay indicated that the rare risk-associated haplotype altered HSD11B1 transcription. HSD11B1 controls tissue levels of biologically active glucocorticoids and thereby influences neuronal vulnerability. Our results indicate that a functional variation in the glucocorticoid system increases the risk for AD, which may have important implications for the diagnosis and treatment of this disease.
- Published
- 2004
- Full Text
- View/download PDF